期刊文献+

茶碱脉冲栓剂的制备及体外释药性考察 被引量:5

Preparation and in Vitro Release Characteristics of Theophylline Pulsed Suppository
原文传递
导出
摘要 目的:制备茶碱脉冲栓剂并评价其体外释药性质。方法:以处方基质中泊洛沙姆、羧甲基纤维素钠(CMC-Na)、聚乙二醇6000(PEG6000)、PEG400的不同用量为因素,以释药时滞及累积释药率为指标采用单因素法筛选栓剂处方组成,并考察填充不同内容物(茶碱原料、茶碱-PVP物理混合物和茶碱-PVP固体分散体)的栓剂的累积释药率。结果:较优基质处方组成为70%泊洛沙姆、6%CMC-Na、12%PEG6000、12%PEG400,其体外释药时滞为4h,90min累积释药率为85%以上;3种填充不同内容物的栓剂累积释药率分别为58.8%、65.8%、91%。结论:所制茶碱脉冲栓剂具有较好的脉冲释药作用。 OBJECTIVE: To prepare theophylline pulsed suppository(TPS) and evaluate its in vitro release characteristics. METHODS: The formulation of TPS was optimized using single factor method taking the amount of base materials including poloxamer, CMC-Na, PEG 6000 and PEG 400 as factors with lag time of drug release and the accumulative drug release rate served as indexes. The accumulative drug release rates of the TPS prepared with different fillers (crude drug of theopylline, theopylline- PVP physical mixture, and the theopylline- PVP solid dispersion) were investigated. RESULTS: The optimal formulation was as follows: 70% poloxamer, 6% CMC-Na, 12% PEG 6000, 12% PEG 400; its lag time of in vitro drug release was about 4 hours and its accumulative drug release rate at 90 min reached more than 85%. The accumulative drug release rates of the suppository prepared with 3 different fillers were 58.8%, 65.8% and 91%, respectively. CONCLUSION: The prepared TPS showed satisfactory pulsed release efficacy.
出处 《中国药房》 CAS CSCD 北大核心 2009年第28期2206-2208,共3页 China Pharmacy
关键词 茶碱 脉冲栓剂 制备 处方 体外释药 Theophylline Pulsed suppository Preparation Formulation In vitro drug release
  • 相关文献

参考文献6

二级参考文献45

  • 1DingJinsong,JiangXuehua.Improving Bioavailability of Naftopidil in Dogs by Using Bioadhesion[J].Journal of Chinese Pharmaceutical Sciences,2001,10(1):29-33. 被引量:3
  • 2王黎明,褚云鸿.达那唑经小鼠阴道和回服给药后血药浓度及子宫内含量的比较[J].生殖与避孕,1994,14(4):275-279. 被引量:1
  • 3谷根妹,樊效琪.紫外分光光度法测定达那唑栓剂的含量[J].药学实践杂志,1995,13(4):229-231. 被引量:1
  • 4朱关珍,杜明昆,郑惠娥,李瑞琴,陆勇娟,金毓翠.丹那唑栓治疗子宫内膜异位症的临床研究[J].中国实用妇科与产科杂志,1995,11(4):225-226. 被引量:17
  • 5Barnes PJ. Theophylline: new perspectives for an old drug.Am J Respir Grit Care Med, 2003, 167(6):813-818
  • 6Rabe KF, Magnussen H, Dent G. Theophylline and selective PDE inhibitors as bronchodilators and smooth muscle relaxants. Eur Respir J, 1995, 8:637-642
  • 7Ise S, Nishimura J, Hirano K, et al. Theophylline attenuates Ca2+ sensitivity and modulates BK channels in porcine tracheal smooth muscle. Br J Pharmacol, 2003, 140(5):939-947
  • 8Ito K, Lira S, Caramori G, et al. A molecular mechanism of action of theophylline: induction of histone deacetylase activity to decrease inflammatory gene expression. Proc Natl Acad Sci USA, 2002, 99(13):8921-8926
  • 9Terao I. Effects of once-daily low-dose administration of sustained-release theophylline on airway inflammation and airway hyperresponsiveness in patients with asthma. Arerugi, 2002,51(4):364-370
  • 10Takeuchi M, Hayakawa A, Takagi K, et al. Theophylline induces apoptosis of the IL-3 activated eosinophils of patients with bronchial asthma. Apoptosis, 1999, 4(6);461-468

共引文献48

同被引文献63

引证文献5

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部